Prednisolone Sodium Phosphate

泼尼松龙磷酸钠

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePrednisolone Sodium Phosphate
Drug Alias NameSolucortPredsolSolu-PredalonePredsolanPrednesol
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsRejection of organ transplantationOcular inflammationDrug Hypersensitivity +[66] 
Global Approved IndicationsRejection of organ transplantationDrug HypersensitivityThyroiditis, Subacute +[56] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1986/05/28
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSeton Pharmaceuticals LlcAdvanz Pharma Ltd
Inactive CompaniesEvolutec GroupZhejiang Xianju Pharmaceutical Co Ltd
Active IndicationsRejection of organ transplantationDrug HypersensitivityThyroiditis, Subacute +[65] 
Inactive IndicationsOcular inflammation

Other Information

ATC CodeA07EA01C05AA04D07AA03 +[10] 
Related LinksWikipediaDrugBankKEGG